Shares of Bausch + Lomb rose in premarket trading Monday after the company said that data from its glaucoma procedure trials was positive. Shares in New York traded 5% higher ahead of the morning bell ...

A minimally invasive surgical procedure for glaucoma designed to reduce intraocular pressure (IOP) has been found to have a high degree of success and significantly reduce the use of drugs for the ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced positive 24-month results from the pivotal U.S.

Please provide your email address to receive an email when new articles are posted on . Ptosis and strabismus occurred in 3.7% and 1.7% of patients, respectively, and 1% had both. Most patients in all ...

Please provide your email address to receive an email when new articles are posted on . Educate patients about glaucoma with nonintimidating language and details tailored to their understanding. Make ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

People who undergo incisional surgery for glaucoma and live in areas with elevated levels of oxidative air pollution may be more likely to have the procedure fail than patients who live in areas with ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

A landmark glaucoma surgery was performed at the Army Hospital using the Hydrus Microstent guided by intraoperative aqueous angiography. This technique enhances drainage in glaucoma patients, marking ...

Glaucoma can silently damage your optic nerve, leading to irreversible vision loss. Learn the early signs, risk factors, and ...

Doctors at the Army Hospital (Research and Referral) have achieved a world first breakthrough in glaucoma surgery, ...

Ophthalmic research focus grows around glaucoma therapy and device development Webinar spotlight covers BL therapy and ELIOS surgical platform technology Sector discussion expands alongside activity ...